Fort Dodge Animal Health

wyeth.com

Fort Dodge Animal Health began in 1912 as a small serum manufacturer based in Fort Dodge, Iowa. Today, the company is headquartered in Overland Park, Kan., and has emerged as a leading global manufacturer of animal health products for the livestock, companion animal, equine, swine, and poultry industries. Fort Dodge is a committed partner to veterinary practitioners, livestock producers, and pet owners worldwide, and is dedicated to meeting their needs and making a difference in the future of animal health.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

ASTORG TO ACQUIRE GLOBAL MEDICAL COMMUNICATIONS AND MARKET ACCESS PLATFORM OPEN HEALTH FROM AMULET CAPITAL PARTNERS

Astorg and Amulet Capital Partners | June 01, 2022

news image

Astorg and Amulet Capital Partners announce that they have signed a binding agreement whereby Astorg will acquire OPEN Health, a leading global provider of scientific communications and market access services to the pharmaceutical industry. Established in 2011 and headquartered in London, UK, OPEN Health is a key partner to its customers in helping them develop strategies for evidence generation and data communication by leveraging their extensive scientific knowledge and relentle...

Read More

Business Insights

EYEPOINT PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

EyePoint Pharmaceuticals, Inc. | April 19, 2022

news image

EyePoint Pharmaceuticals, Inc. a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2016 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 56,500 shares of EyePoint Ph...

Read More

IONIS AND GENUITY SCIENCE ANNOUNCE AGREEMENT DESIGNED TO RAPIDLY TRANSLATE GENOMIC INSIGHTS INTO THERAPEUTICS

Prnewswire | October 01, 2020

news image

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration aimed at accelerating the discovery and development of innovative therapeutics across a range of up to 20 diseases. The collaboration is expected to play an important role in allowing Ionis to continue delivering transformational medicines to patients for many years to come. Genuity Science's approach comb...

Read More

Pharma Tech

AMERISOURCEBERGEN PARTNERS WITH CHRONICLED TO OPTIMIZE PHARMACEUTICAL CHARGEBACK ACCURACY USING BLOCKCHAIN-POWERED TECHNOLOGY

AmerisourceBergen | April 22, 2022

news image

Global healthcare company AmerisourceBergen announced its partnership with Chronicled, the administrator of the MediLedger Network, to leverage a new blockchain-powered solution designed to enhance pharmaceutical chargeback accuracy and significantly reduce chargeback rejections. The blockchain solution will allow AB to streamline and optimize the complex process of pharmaceutical chargebacks while creating greater connectivity for its suppliers and customers. Over the past three years, AB has c...

Read More
news image

Business Insights

ASTORG TO ACQUIRE GLOBAL MEDICAL COMMUNICATIONS AND MARKET ACCESS PLATFORM OPEN HEALTH FROM AMULET CAPITAL PARTNERS

Astorg and Amulet Capital Partners | June 01, 2022

Astorg and Amulet Capital Partners announce that they have signed a binding agreement whereby Astorg will acquire OPEN Health, a leading global provider of scientific communications and market access services to the pharmaceutical industry. Established in 2011 and headquartered in London, UK, OPEN Health is a key partner to its customers in helping them develop strategies for evidence generation and data communication by leveraging their extensive scientific knowledge and relentle...

Read More
news image

Business Insights

EYEPOINT PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

EyePoint Pharmaceuticals, Inc. | April 19, 2022

EyePoint Pharmaceuticals, Inc. a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2016 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 56,500 shares of EyePoint Ph...

Read More
news image

IONIS AND GENUITY SCIENCE ANNOUNCE AGREEMENT DESIGNED TO RAPIDLY TRANSLATE GENOMIC INSIGHTS INTO THERAPEUTICS

Prnewswire | October 01, 2020

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration aimed at accelerating the discovery and development of innovative therapeutics across a range of up to 20 diseases. The collaboration is expected to play an important role in allowing Ionis to continue delivering transformational medicines to patients for many years to come. Genuity Science's approach comb...

Read More
news image

Pharma Tech

AMERISOURCEBERGEN PARTNERS WITH CHRONICLED TO OPTIMIZE PHARMACEUTICAL CHARGEBACK ACCURACY USING BLOCKCHAIN-POWERED TECHNOLOGY

AmerisourceBergen | April 22, 2022

Global healthcare company AmerisourceBergen announced its partnership with Chronicled, the administrator of the MediLedger Network, to leverage a new blockchain-powered solution designed to enhance pharmaceutical chargeback accuracy and significantly reduce chargeback rejections. The blockchain solution will allow AB to streamline and optimize the complex process of pharmaceutical chargebacks while creating greater connectivity for its suppliers and customers. Over the past three years, AB has c...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us